biopharmaceutical - Blogging About What's Possible

Recent posts

Answering the Call with Compliance-Ready LC-MS Solutions for Oligonucleotide Analysis

By December 11, 2020

Oligonucleotides, or short strands of DNA or RNA, continue to increase in popularity. In addition to their essential role as primers and probes in the expanding clinical DNA testing and diagnostics market, they’re also seeing… Read more >

Categories: Pharmaceutical, Technologies
Tags: , , ,

Boosting Biopharma Productivity with Routine LC-MS

By December 1, 2020

As scientific advances continue to carry researchers into new arenas, it is vital that technology evolves in tandem. At Waters, we understand that it is only by leveraging fit-for-purpose technologies that researchers are able to… Read more >

Categories: Pharmaceutical, Technologies
Tags: , , ,

Learning from User Experience

By May 8, 2019

What does “intelligence” mean in the context of biopharma analysis? Given the complex setting, much of the answer comes down to the task a user needs to complete, along with the question of who exactly… Read more >

Categories: Pharmaceutical, Technologies
Tags: , , , ,

The Future of Biopharmaceutical Development Just Became Brighter

By February 28, 2019

In late January, I traveled to WCBP (Well Characterized Biological Products), an industry conference that is hosted every year by the CASSS organization. It serves as a forum that brings together biopharmaceutical industry professionals and… Read more >

Categories: Pharmaceutical
Tags: ,

Routine Mass Analysis Enables Greater Productivity in Biopharma Development

By January 15, 2019

Its great promise for routine monitoring of biologic drugs begs the question: Just when will LC-MS analysis become a true bedrock analytical tool for scientists and technicians throughout biopharma?

Categories: Pharmaceutical
Tags: , , ,

Enhancing Analytical Productivity by Breaking Down Silos – Part 3

By January 9, 2019

Analytical data can be so much more than a historical point in time documented in a single report. In fact, biopharmaceutical organizations can use LC-MS data to build a continuum of compliance.

Categories: Pharmaceutical
Tags: , , , , , , , , , ,

Enhancing Analytical Productivity by Breaking Down Silos (Part 2)

By October 30, 2018

For biopharmaceutical organizations working with contract labs, it’s important to consider how data and methods will be transferred and how generated data will be managed so that it meets data integrity and compliance requirements.

Categories: Pharmaceutical
Tags: , , , , , , ,

I Resolve to Get Better mAb Separations

By August 8, 2018

We listened and learned how scientists separate mAbs and ADCs; then we designed a novel column for LC-MS bioseparations A critical step toward the prolific and successful use of monoclonal antibodies (mAb) as biotherapeutics occurred… Read more >

Categories: Columns
Tags: , , , , , , , ,

Enhancing Analytical Productivity by Breaking Down Silos (Part 1)

By July 20, 2018

Analytical methods transfer. Data integrity. A changing and more stringent regulatory landscape. All this, and more, impacts productivity in upstream and downstream biopharmaceutical processes. How is Waters looking to help address development challenges for biologics and biosimilars?

Categories: Pharmaceutical
Tags: , , , , , ,

The Expanding Role of Mass Spec for Peptide Mapping in Multi-Attribute Monitoring Assays

By July 12, 2018

There are two primary multi-attribute monitoring (MAM) assay choices for biologic development and QC: subunit protein mass analysis and peptide mapping by LC-MS. Here we explore how peptide mapping LC-MS MAM workflows are being used.

Categories: Pharmaceutical
Tags: , , , , , , , , , ,